NeuResto Therapeutics was founded to pursue novel approaches to neuroprotection for ischemic stroke and wet AMD and neurorestoration for diseases such as TBI/concussion.
Nicolas G. Bazan, M.D., Ph.D. | Co-founder, President & CEO
- Dr. Bazan is the Director of Neuroscience at the Louisiana State University Health Sciences Center, where he oversees over 90 researchers.
- Expert in experimental models of stroke and traumatic brain injury, with over 35 years of continuous NIH funding.
- Decades of experience in pharmaceutical development regarding eye and brain medications.
Nicos Petasis, Ph.D. | Co-founder, Chief Scientific Officer
- Dr. Petasis is a faculty member and Professor of Chemistry and Pharmacology in the University of Southern California's Department of Chemistry.
- Decades of experience in pharmaceutical development regarding the chemical processes of cancer and other medications.
Founders & Leadership Team
Scientific Advisory Board
John E. Dowling, Ph.D.
- Dr. Dowling is a Professor Emeritus at Harvard University, a member of the National Academy of Sciences, and a fellow of the American Academy of Arts and Sciences
- Contributed to our understanding of the functional organization of the retina, its synaptic organization, the electrical responses of the retinal neurons, and the mechanisms underlying neurotransmission and neuromodulation in the retina.
Edmond H. Fischer, Ph.D.
- Dr. Fischer is the 1992 Nobel Prize in Physiology or Medicine co-recipient for describing how reversible phosphorylation works as a switch to activate proteins and regulate various cellular processes.
- Professor Emeritus of biochemistry at the University of Washington.
Bengt I. Samuelsson, Ph.D.
- Dr. Samuelsson is the 1982 Nobel Prize for Physiology or Medicine co-recipient for discoveries concerning prostaglandins and related substances.
- Served on the board of directors of Pharmacia AB, NicOx S.A. and Schering AG and is an advisor to the venture capital fund HealthCap.
Pierluigi Nicotera, Ph.D.
- Dr. Nicotera is the Scientific Director and Chairman of the Executive Board of the German Center for Neurodegenerative Diseases and has been a member of the German Academy of Science since 2016.
- Has presented his discoveries on ‘Molecular switches in neuronal cell death’ (Lecture at the 37th Nobel Conference on Apoptosis, Stockholm, 2002) and on ‘Synaptic damage in neurodegeneration’ (Lecture at the Nobel Conference on Cell Cycle and Apoptosis. 200-year Anniversary of the Karolinska Institute. Stockholm, Sweden, 2010).
Hernan A. Bazan, M.D., DFSVS, FACS | Co-founder, Chief Medical Officer
- Dr. Bazan is an academic vascular surgeon specializing in acute stroke treatment.
- CEO & Co-founder of South Rampart Pharma, LLC.